Warning Letter Roundup: FDA Targets Firms for Quality Failures

Drug GMP Report
A A
The FDA hit five facilities with warning letters, citing them for multiple violations, including a failure to test for conformity.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00